AbbVie Inc. ABBV delivered better-than-expected third-quarter 2019 earnings and revenues. The company also raised the lower end of the guidance for 2019 adjusted earnings. Shares inched up around 1% in pre-market trading.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,